Trump officials tried to ‘bully’ FDA over Covid treatments, House panel says

Congressional investigation finds new evidence of efforts to override health decisions early in pandemic

Officials in the Trump White House tried to pressure health experts to reauthorize a discredited Covid treatment, according to a congressional investigation.

A report published on Wednesday by the Democratic-led House select subcommittee on the coronavirus crisis contained new evidence of efforts to override Food and Drug Administration (FDA) decisions early in the pandemic.